Medpace Holdings, Inc. MEDP Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | 21.1%0.0pp | 21.2%+3.3pp | 17.9%-1.2pp | 19.1%+1.7pp | |
| Net margin | 17.8%-1.3pp | 19.2%+4.2pp | 15%-1.8pp | 16.8%+0.9pp | |
| EBITDA margin | 22.3%-0.3pp | 22.6%+3.3pp | 19.3%-1.4pp | 20.6%+1.4pp | |
| Free cash flow margin | 26.9%-0.2pp | 27.1%+6.1pp | 21%-3.0pp | 24.1%+3.5pp | |
| Returns | |||||
| Return on equity | 70.2%+11.8pp | 58.4%-1.4pp | 59.8%+23.2pp | 36.6%+16.0pp | |
| Return on assets | 22.1%+0.6pp | 21.5%+2.7pp | 18.8%+2.5pp | 16.3%+4.4pp | |
| Return on invested capital | 220%+123pp | 96.9%+42.6pp | 54.3%+14.2pp | 40.1%+12.5pp | |
| Efficiency | |||||
| Asset turnover | 1.2×+0.1× | 1.1×-0.1× | 1.3×+0.3× | 1×+0.2× | |
| Liquidity | |||||
| Current ratio | 0.7×-0.2× | 0.9×+0.3× | 0.6×+0.2× | 0.4×-0.8× | |
| Quick ratio | 0.7×-0.2× | 0.9×+0.3× | 0.6×+0.2× | 0.4×-0.8× | |
| Cash ratio | 0.4×-0.2× | 0.6×+0.3× | 0.3×+0.2× | 0×-0.8× | |
| Leverage | |||||
| Debt-to-equity | 0.3×+0.1× | 0.2×-0.1× | 0.3×-0.2× | 0.5×+0.4× | |
| Debt-to-assets | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.2×+0.1× | |
| Net debt / EBITDA | -0.6×+0.5× | -1.1×-0.9× | -0.2×-0.8× | 0.6×+2.0× | |
| Interest coverage | 41.9×+24.0× | 17.9×— | —— | —— | |
| Per Share | |||||
| Book value per share | $15.55-39.7% | $25.79+46.9% | $17.55+53.0% | $11.48-54.6% | |
| Valuation | |||||
| Market capitalization | $15.82B+53.2% | $10.33B+9.7% | $9.42B+42.5% | $6.61B-15.5% | |
| Enterprise value | $15.46B+57.7% | $9.81B+5.0% | $9.34B+37.6% | $6.79B-9.6% | |
| Price / earnings | 35.1×+9.5× | 25.5×-7.8× | 33.3×+6.4× | 26.9×-16.1× | |
| Price / sales | 6.3×+1.4× | 4.9×-0.1× | 5×+0.5× | 4.5×-2.3× | |
| Price / book | 34.5×+22.0× | 12.5×-4.3× | 16.8×-0.3× | 17.1×+8.9× | |
| EV / EBITDA | 27.5×+6.9× | 20.6×-5.1× | 25.7×+3.2× | 22.5×-11.6× | |
| EV / sales | 6.1×+1.5× | 4.6×-0.3× | 5×+0.3× | 4.6×-1.9× | |
| Free cash flow yield | 4.3%-1.2pp | 5.5%+1.3pp | 4.2%-1.1pp | 5.3%+2.3pp | |
| Earnings yield | 2.9%-1.1pp | 3.9%+0.9pp | 3%-0.7pp | 3.7%+1.4pp | |
| PEG ratio | 3×+2.4× | 0.6×-1.6× | 2.2×+1.4× | 0.8×-0.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Medpace Holdings, Inc.'s ratios come from?
- Every ratio is computed from Medpace Holdings, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
